The scAtlasVAE model integrates scRNA-seq data to create a CD8+ T cell atlas, enhancing understanding of immune responses in ...

Scientists created a new therapeutic design for glioblastoma, the deadliest form of brain cancer. The lab engineered molecules called trispecifics that connect cancer-killing T cells with not just one ...

Amylyx Pharmaceuticals Announces Pivotal Phase 3 LUCIDITY Trial Design for GLP-1 Receptor Antagonist (Avexitide) in Post-Bariatric Hypoglycemia ...

Hematology blood disorders are diseases that affect the blood and hematopoietic system’s functions. It includes leukemia, ...

Hepatitis B virus (HBV) has a narrow host range, mainly infecting hominoids. A new study reveals the structural differences in the liver cell receptor (NTCP) between humans and monkeys, explaining why ...

Hepatitis B virus (HBV) infection is a leading cause of chronic liver diseases, that spreads among individuals through blood or body fluids. According ...

A newly approved immunotherapy can help adults with a difficult-to-treat form of leukemia, clinical trial results show.

A study reveals why monkeys resist HBV infection, showing that specific amino acid differences in their NTCP receptor prevent ...

A subset of cells in the brain coordinate bladder muscle and sphincter function to precisely control urination, according to new research.

A groundbreaking study has identified a naturally occurring ligand derived from vitamin B6 that can activate immune cells to ...

Adoptive cell transfer with chimeric antigen receptor (CAR)-expressing T cells can induce remarkable complete responses in ...

Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“ Innate ” or the “ Company ”) today announced that abstracts related to lacutamab health-related quality of life and translational data from the ...